Evidence map›Paper›PMID 30357856›Full record

ArticleJournal of medical primatology2019

Characterization of glucose-stimulated insulin release protocols in african green monkeys (Chlorocebus aethiops).

Shervin Liddie, Haruka Okamoto, Jesper Gromada, Matthew Lawrence

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical primatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shervin LiddieRxGen Inc., New Haven, Connecticut.ORCID 0000-0003-4694-5299
Haruka OkamotoRegeneron Pharmaceuticals Inc., Tarrytown, New York.
Jesper GromadaRegeneron Pharmaceuticals Inc., Tarrytown, New York.
Matthew LawrenceRxGen Inc., New Haven, Connecticut.
Biomedical Research Foundation · USRegeneron (United States) · US

Funding

Regeneron Pharmaceuticals Inc.RxGen Inc.
6 · The paper itself

Abstract

backgroundManagement of diabetes remains a major health and economic challenge, demanding test systems in which to develop new therapies. These studies assessed different methodologies for determining glucose tolerance in green monkeys.

methodsTwenty-eight African green monkeys between 4 and 24 years old underwent single or repeat intravenous glucose tolerance testing (IVGTT), oral glucose tolerance testing (OGTT), and/or graded glucose infusion testing.

resultsGeriatric monkeys exhibited glucose intolerance with impaired glucose-stimulated insulin secretion following IVGTT. Repeat IVGTT and OGTT assessments were inconsistent. Monkeys with low glucose-stimulated insulin secretion after graded glucose infusion exhibited elevated blood glucose levels.

conclusionIVGTT and graded glucose infusion protocols revealed differences in glucose tolerance among green monkeys at single time points, including age-dependent differences suggestive of shifts in pancreatic beta-cell functional capacity, but care should be applied to study design and the interpretation of data in the setting of longitudinal studies.

Indexed as

Insulin SecretionAnimalsChlorocebus aethiopsFemaleGlucose Tolerance TestMaleAfrican green monkeyagingdiabetesgraded glucose infusioninsulinopenicintravenous glucose tolerance testnonhuman primatesoral glucose tolerance testplasma insulinvervet

Identifiers

PMID30357856
PMCPMC6587791
OpenAlexW2898327374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.